
Results 1 - 20 of 9,734 in Pharmaceuticals
AEterna Zentaris Announces Results from its European Phase 3 Study...
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its European efficacy trial Z-036 in benign prostatic hyperplasia , with cetrorelix pamoate. Comment?
Low-fat dogma, low-carb vilification continues on because of groupthink
I was recently encouraged by low-carb diabetes legend Dr. Richard Bernstein to look up the term "groupthink" on Wikipedia for an apt description of what is happening with the relentless and might I add stubborn opposition to healthy low-carb living even in the midst of a growing body of scientific evidence in support of this way of eating. Comment?
TSX flat amid RIM China announcement
The Toronto stock market was little changed late Monday morning, dragged down by lower commodity stocks as the American dollar strengthened. Comment?
Monday outlook: Stocks head for lower open amid higher U.S. dollar
The Canadian Press Malcolm Morrison The Toronto stock market headed for a lower opening Monday as a surging American currency sent commodity prices lower. Comment?
Thompson Creek Metals plans to increase capital expenditures in 2010
Thompson Creek Metals Company Inc. is budgeting US$298 million for capital expenditures in 2010 to expand the Endako Mine project and proceed with maintenance and upgrades postponed to conserve cash in 2009. Comment?
The pricetag could be going up for the pharmaceutical industry, which has already agreed to pony up $80 billion to President Barack Obama's health overhaul effort. Comment?
House Panel Probes Prescription Drug Prices
The rate of inflation is hovering near zero, but the price of prescription drugs seems to keep going up. Comment?
German Stocks Decline as Sieme...
German stocks dropped after a government report showed factory orders in Europe's biggest economy unexpectedly declined for the first in eight months. Comment?
The Role of PharmEcovigilance in Reducing the Environmental Footprint of Pharmaceuticals
RUHOY, I. S. AND C. G. DAUGHTON. The Role of PharmEcovigilance in Reducing the Environmental Footprint of Pharmaceuticals. Comment?
Research and Markets: The Pharmaceutical Market: Serbia - Ideal for...
Research and Markets: The Pharmaceutical Market: Serbia - Ideal for Executives Wanting to Understand the Key Drivers in Pharmaceutical Markets and Have Access to a Wealth of Statistical Data This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth ... Comment?
Synta Pharmaceuticals Announces Encouraging Results for Elesclomol in ...
Synta Pharmaceuticals Corp. , a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the results of a study evaluating the activity of elesclomol against acute myeloid leukemia cell lines and primary leukemic blast cells from AML patients, ... Comment?
Drugmakers' support for health overhaul tested
The pricetag could be going up for the pharmaceutical industry, which has already agreed to pony up $80 billion to President Barack Obama's health overhaul effort. Comment?
New Report Recommends Banning Gifts Between Doctors and Drug Companies
Attorney General Anne Milgram released a report this month from the Division of Consumer Affairs recommending new regulations to curtail the potential for conflicts of interest between doctors and pharmaceutical companies and medical device manufacturers. Comment?
McKesson to launch PROmanager-Rx at ASHP in Las Vegas
Healthcare company McKesson Corporation reported on Monday that it will launch the PROmanager-Rx system at the 44th Midyear Clinical Meeting and Exhibition of the American Society of Health-System Pharmacists in Las Vegas. Comment?
Pharmaceutical industry may have to cough up more
w/Photo
... ed. The nation would vote to maintain private coverage, the have watched the failure and want no part of it. Pharmaceuticals have already lowered prices, fired employees, lost stock profits, how much more room is left to concede? Comment?
European Stocks, U.S. Index Fu...
European stocks and U.S. index futures fell as a decline in metal prices weighed on basic- resource companies and investors increased bets the Federal Reserve may raise interest rates in the first quarter of 2010. Comment?
Phase III Einstein-Extension Study of Bayer 's Rivaroxaban Shows...
Treatment of Venous Thromboembolism : Phase III EINSTEIN-Extension Study of Bayer's Rivaroxaban Shows Significant Benefit in the Prevention of Secondary Symptomatic VTE Impressive 82% Relative Risk Reduction in the Recurrence of Symptomatic VTE over Patients Treated with Placebo / Positive Benefit-Risk profile for Rivaroxaban Confirmed / First ... Comment?
Niche Opportunities Open In Pharma
w/Photo
... wondering when and upon whose neck the ax will fall next. Mark Murcko, chief technology officer at Vertex Pharmaceuticals , says that "there is a lot of anxiety" among chemists, particularly at larger companies. The market for chemists in pharma is ... Comment?
Pharmaceutical industry may have to bow to pressure, give ...
... a health care consultant. "The drug companies are going to have to pay more." About $320 billion in pharmaceuticals will be sold in the U.S. next year, according to IMS Health Inc., a data tracking firm. But that is expected to grow by less than 5 ... Comment?
Dems try to move health care ahead, Drugmakers' support tested
Senate Democrats have had their presidential pep talk and now it's back to work on the thorny issues in the path of passing health care legislation. Comment?